ERBB2 and breast cancer: By leveraging the pre-trained weights of DarkNet-53, the model is equipped with the ability to capture hierarchical representations from medical images, enhancing its capability to discern subtle patterns indicative of breast cancer with 98% accuracy Jabeen et al.17 GNN model is used to predict the Human Epidermal Growth Factor Receptor 2 (HER2) status of breast cancer based on histopathological images.